These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 3538736

  • 1. Insulin secretion and insulin sensitivity defects are a common feature of mild, clinically homogeneous, recently diagnosed type II (non-insulin-dependent) diabetics.
    Pisu E, Lombardi A, De Benedictis D, Bozzo C, Chiara E, Baggiore C, Bruno A, Cravero L, Pagano G, Lenti G.
    Acta Diabetol Lat; 1986; 23(3):215-25. PubMed ID: 3538736
    [Abstract] [Full Text] [Related]

  • 2. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR, Fink R, Griffin J, Olefsky JM, Kolterman OG.
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [Abstract] [Full Text] [Related]

  • 3. [Insulin resistance and insulin secretion in type II non-obese diabetics].
    Pelikánová T, Válek J, Kazdová L, Saudek F, Karasová L.
    Cas Lek Cesk; 1994 Mar 21; 133(6):172-6. PubMed ID: 8156572
    [Abstract] [Full Text] [Related]

  • 4. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
    Mandarino LJ, Gerich JE.
    Diabetes Care; 1984 Mar 21; 7 Suppl 1():89-99. PubMed ID: 6376034
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome.
    Lewy VD, Danadian K, Witchel SF, Arslanian S.
    J Pediatr; 2001 Jan 21; 138(1):38-44. PubMed ID: 11148510
    [Abstract] [Full Text] [Related]

  • 7. Mild type II diabetes markedly increases glucose cycling in the postabsorptive state and during glucose infusion irrespective of obesity.
    Efendic S, Karlander S, Vranic M.
    J Clin Invest; 1988 Jun 21; 81(6):1953-61. PubMed ID: 3290257
    [Abstract] [Full Text] [Related]

  • 8. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A, Defronzo RA, Thorin D, Jequier E, Felber JP.
    Diabete Metab; 1988 Jun 21; 14(4):443-51. PubMed ID: 3066652
    [Abstract] [Full Text] [Related]

  • 9. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
    Gumbiner B, Polonsky KS, Beltz WF, Griver K, Wallace P, Brechtel G, Henry RR.
    J Clin Endocrinol Metab; 1990 Jun 21; 70(6):1594-602. PubMed ID: 2189885
    [Abstract] [Full Text] [Related]

  • 10. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.
    DeFronzo R, Deibert D, Hendler R, Felig P, Soman V.
    J Clin Invest; 1979 May 21; 63(5):939-46. PubMed ID: 376552
    [Abstract] [Full Text] [Related]

  • 11. Insulin clamp-derived measurements of insulin sensitivity and insulin secretion in lean and obese asian type 2 diabetic patients.
    Suraamornkul S, Kwancharoen R, Ovartlarnporn M, Rawdaree P, Bajaj M.
    Metab Syndr Relat Disord; 2010 Apr 21; 8(2):113-8. PubMed ID: 20059360
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Insulin resistance, but normal basal rates of glucose production in patients with newly diagnosed mild diabetes mellitus.
    Hother-Nielsen O, Beck-Nielsen H.
    Acta Endocrinol (Copenh); 1991 Jun 21; 124(6):637-45. PubMed ID: 2068893
    [Abstract] [Full Text] [Related]

  • 14. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.
    Meneilly GS, Elliott T.
    Diabetes Care; 1999 Jan 21; 22(1):112-8. PubMed ID: 10333911
    [Abstract] [Full Text] [Related]

  • 15. The interrelationship between insulin secretion and action in type 2 diabetes mellitus with different degrees of obesity: evidence supporting central obesity.
    Duman BS, Turkoglu C, Gunay D, Cagatay P, Demiroglu C, Buyukdevrim AS.
    Diabetes Nutr Metab; 2003 Aug 21; 16(4):243-50. PubMed ID: 14768774
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect.
    Cavallo-Perin P, Cassader M, Bozzo C, Bruno A, Nuccio P, Dall'Omo AM, Marucci M, Pagano G.
    J Clin Invest; 1985 May 21; 75(5):1659-65. PubMed ID: 3889056
    [Abstract] [Full Text] [Related]

  • 17. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.
    Garvey WT, Olefsky JM, Griffin J, Hamman RF, Kolterman OG.
    Diabetes; 1985 Mar 21; 34(3):222-34. PubMed ID: 3882489
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA, Barzilai N, Simonson DC.
    J Clin Endocrinol Metab; 1991 Dec 21; 73(6):1294-301. PubMed ID: 1955512
    [Abstract] [Full Text] [Related]

  • 19. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
    Baron AD, Schaeffer L, Shragg P, Kolterman OG.
    Diabetes; 1987 Mar 21; 36(3):274-83. PubMed ID: 2879757
    [Abstract] [Full Text] [Related]

  • 20. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.
    Kolterman OG, Gray RS, Griffin J, Burstein P, Insel J, Scarlett JA, Olefsky JM.
    J Clin Invest; 1981 Oct 21; 68(4):957-69. PubMed ID: 7287908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.